<DOC>
	<DOCNO>NCT02055963</DOCNO>
	<brief_summary>The goal clinical research study learn MinocinÂ® ( minocycline ) reduce certain side effect surgery patient head neck cancer ( pain , fatigue , disturbed sleep ) . In study , minocycline compare placebo . A placebo drug . It look like study drug , design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>Minocycline Postsurgical Symptom Reduction Head Neck Cancer</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group . This do one know one study group well , , bad group . You equal chance group . - If Group 1 , receive minocycline . - If Group 2 , receive placebo . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : You take minocycline/placebo 2 time every day ( 12 hour apart ) . This 1-2 day surgery 3 week surgery . Most time , take minocycline/placebo mouth feed tube . If unable take mouth feeding tube , receive vein every 12 hour . You take study drug/placebo full glass ( 8 ounce ) water . You may take without food , cause upset stomach , take food . You lie least 30 minute take study drug/placebo reduce risk side effect . You also give standard drug help decrease risk side effect surgery . You may ask study staff information drug give risk . Study Visits : After agree participate study , day surgery , 1 3 day surgery , 2 time week end study , complete questionnaire side effect experience . This take 5 minute complete . When home , complete questionnaire phone computerized system . You answer question use telephone keypad . After agree participate study , 1 3 day surgery , complete 2 questionnaire quality life . This take 10 minute complete . After agree participate study , soon surgery , 1 week surgery discharge hospital , saliva collect used test marker inflammation . If possible , blood ( 2 teaspoon ) also draw test marker inflammation . This regular blood draw would need extra needle stick . Length Study : You take study drug/placebo 3 week surgery . You longer able take study drug/placebo disease get bad , intolerable side effect occur , unable follow study direction . Your participation study follow-up visit . Follow Visit : At 3 week surgery , return clinic . The following test procedure perform : - Saliva collect used test marker inflammation . - You complete 3 questionnaire quality life side effect feel . This take 20 minute complete . - If possible , blood ( 2 teaspoon ) also draw test marker inflammation . This regular blood draw would need extra needle stick . This investigational study . Minocycline FDA approve commercially available treatment bacterial infection . Using minocycline try reduce side effect surgery patient head neck cancer investigational . Up 130 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Patients head neck cancer undergo either flap nonflap surgery ( limited parotidectomy , hard palate maxillectomy glossectomy , mandibulectomy , procedure neck dissection ) MD Anderson Cancer Center . 2 . Patients &gt; 18 year old . 3 . Patients undergone surgery past 6 month . Patients may neoadjuvant chemotherapy prior surgery . 4 . Patients must normal renal function test prior renal disease . The screening cut serum creatinine &lt; 1.5mg/dL . 5 . Patients must normal hepatic function test prior liver disease : ( 1 ) The screening result alanine aminotransferase ( ALT ) must &lt; 2 time upper limit normal . ( 2 ) The screening result aspartate aminotransferase ( AST ) , available , must &lt; 2 time upper limit normal . 6 . Patients speak English Spanish ( due novel research complexity , accrue Englishspeaking Spanishspeaking patient protocol ) . 7 . Patients must willing able review , understand , provide write consent . 8 . Patients must willing discontinue take dong quai and/or St. John 's wort . 1 . Patients take medication ( include minocycline ) condition potentially preclude use study medication intervention determine treat physician . 2 . Patients enrol another symptom management trial receive active treatment another clinical trial . 3 . Patients history clinically significant cutaneous drug reaction , hypersensitivity reaction , anaphylaxis serious adverse reaction anesthetic analgesic medication use study . 4 . Patients hypersensitivity tetracycline . 5 . Patients vitamin K antagonist ( i.e. , warfarin ) . 6 . Patients take tetracycline within last 15 day . 7 . Patients opioid therapy last 4 week . 8 . Patients bile duct obstruction . 9 . Patients pregnant . 10 . Patients INR &gt; 1.5 . 11 . Patients autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Head And Neck Cancer</keyword>
	<keyword>Postsurgical symptom reduction</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Dynacin</keyword>
	<keyword>Minocin</keyword>
	<keyword>Minocin PAC</keyword>
	<keyword>Myrac</keyword>
	<keyword>Solodyn</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar pill</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>